Skip to content
DataLookout
Menu

RapamycinNCT05836025

Effect of Rapamycin in Ovarian Aging

StatusCompleted
PhasePhase 2
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Nov 18, 2026 Show 5 more changesShow less
    • Eligibility criteria expanded, about 3 words
    • Trial completed
    • Study completion date changed from estimate of Sep 2026 to Oct 21, 2025
    • Secondary endpoints: 4 to 3
    • Site details revised
  2. Minor Primary completion date changed from estimate of Oct 2025 to Oct 21, 2025v6
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Apr 2025 to Oct 2025
    • Study completion date: Dec 2025 to Sep 2026
    • Site details revised
    v5
  4. Notable Primary completion date: May 2024 to Apr 2025
    • Study completion date: Dec 2024 to Dec 2025
    v4
  5. Notable Eligibility criteria expanded, about 6 words
    • Primary completion date: May 31, 2024 to May 2024
    • Start date changed from estimate of Jun 2023 to Jun 1, 2023
    • Secondary endpoints revised (4)
    v3
  6. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Apr 2023 to Jun 2023
    • Primary completion date: Apr 2024 to May 31, 2024
    • Site details revised
    v2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Measure of Ovarian Reserve
Timeframe: Baseline, 12 months post-intervention

Secondary (3)

Antral Follicle Counts (AFC)
Estradiol (E2) Level
FSH Level

Arms and interventions

RapamycinExperimental

Participants randomized to the treatment arm will receive 5mg/week of rapamycin orally, for 12 weeks (3 months).

PlaceboPlacebo comparator

Participants randomized to the placebo arm will receive placebo orally, for 12 weeks (3 months).

Drugs: Rapamycin

Other: Placebo

Sites

1 site in 1 country

  • Columbia University Irving Medical Center / NewYork-Presbyterian HospitalNew York, New York, United States